Exact Mass: 360.03263519999996
Exact Mass Matches: 360.03263519999996
Found 197 metabolites which its exact mass value is equals to given mass value 360.03263519999996,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyraclofos
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
dorzolamide hydrochloride
C10H16N2O4S3·HCl (360.00389520000004)
D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor
2-(3-Benzyltriazolo[4,5-d]pyrimidin-7-yl)sulfanyl-1,3-benzoxazole
VAS2870 is a NADPH oxidase (NOX) inhibitor.
4-Methylgallic acid 3-glucuronide
4-Hydroxy-3-(2'-hydroxy-[1,1'-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile
C20H12N2O3S (360.0568602000001)
fructose-6-phosphate pyruvate
C9H13O13P (360.00937780000004)
Ritipenem acetoxymethyl ester
Glucoputranjivin
Glucoputranjivin is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoputranjivin is soluble (in water) and an extremely strong acidic compound (based on its pKa). Glucoputranjivin can be found in a number of food items such as wasabi, white mustard, chinese mustard, and horseradish, which makes glucoputranjivin a potential biomarker for the consumption of these food products.
ethyl loflazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
{3-[5-(2-Phenyleth-1-ynyl)-2-thienyl]-1H-pyrazol-1-yl}(2-thienyl)methanone
1,3,6,8-Tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracen-2-carbonsaeure-methylester|1,3,6,8-tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracene-2-carboxylic acid methyl ester|2-Hydroxymethyl-1,3,6,8-tetrahydroxyanthrachinon-7-carbonsaeure-methylester|Rhodocadonsaeure
Methyl 18-Bromo-(13E,17E)-octadeca-9,17-diene-5,7,15-triynoate
6-bromo-(5E,15Z)-octadeca-5,15-diene-11,13,17-triynoic acid methyl ester
(3Z,11Z,7S*,9R*,10R*)-13-methoxy-6-chloro-9-bromo-7:10-epoxypentadeca-3,11-dien-1-yne
2,3-Dihydro-4-O-demethylaustocystin A
C18H13ClO6 (360.04006280000004)
3,3,4-tri-O-methylflavellagic acid|3,3,4-trimethoxyflavellagic acid
2,3-Dihydro-6-O-demethylaustocystin A
C18H13ClO6 (360.04006280000004)
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based on: CCMSLIB00000848321]
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based: Match]
Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate
Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate
(CYCLOHEXYLAMINOMETHYL)TRIETHOXYSILANE
C15H20Cl2Zr (359.99890600000003)
Ixazomib
A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixazomib citrate, it is used in combination therapy for treatment of multiple myeloma. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
6-AMINO-2-(BENZO[D][1,3]DIOXOL-5-YLMETHYL)-4-BROMOISOINDOLIN-1-ONE
C16H13BrN2O3 (360.01094880000005)
Fosazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Urea, N-(3,4-dichlorophenyl)-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)- (9CI)
2-(BETA-ANILINO)VINYL-3-ETHYL THIAZOLIUM IODIDE
C13H17IN2S (360.01571520000005)
ETHYL 3-(4-BROMOPHENYL)-4-CYANO-5-ETHYL-1-METHYL-1H-PYRROLE-2-CARBOXYLATE
C17H17BrN2O2 (360.04733219999997)
2-(2-Iodo-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C13H18BIO3 (360.03936980000003)
A-769662
C20H12N2O3S (360.0568602000001)
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM.
7-(2-bromoethoxy)-5-hydroxy-2-phenylchromen-4-one
C17H13BrO4 (359.99971580000005)
methyl 4-(4-chloro-[1]benzothiolo[2,3-d]pyrimidin-2-yl)cyclohexane-1-carboxylate
2-[2-[4-(4-chlorophenoxy)anilino]-1,3-thiazol-4-yl]acetic acid
C17H13ClN2O3S (360.0335378000001)
4,4-BISMALEIMIDODIPHENYLETHER(44ODA/BMI)
C20H12N2O5 (360.07461820000003)
Hexamethonium bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) antagonist, with mixed competitive and noncompetitive activity. Hexamethonium Bromide has anti-hypertensive activity. Hexamethonium Bromide attenuates sympathetic activity and blood pressure in spontaneously hypertensive animal models[1][2][3][4].
2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
1-(3,4-DIFLUOROBENZYL)-2-OXO-N-(THIOPHEN-2-YLMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
a-D-erythro-Pentofuranosyl chloride, 2-deoxy-, dibenzoate (9CI)
4-Chloro-1-(phenylsulfonyl)-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
2-Iodo-4-methyl-3-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridine-5-carbo nitrile
Methyl 4-O-benzoyl-6-bromo-6-deoxy-α-D-glucopyranoside
Ethyl2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate
C16H13BrN2O3 (360.01094880000005)
1-[3,6-bis(4-chlorophenyl)-1H-1,2,4,5-tetrazin-2-yl]propan-1-one
TGR5 Receptor Agonist
TGR5 Receptor Agonist (CCDC), a potent Takeda G protein-coupled receptor 5 (TGR5; GPCR19) agonist, shows improved potency in the U2-OS cells and melanophore cells with pEC50s of 6.8 and 7.5, respectively. TGR5 Receptor Agonist can induce peripheral and central hypersensitivity to bladder distension in mice, and increase intracellular Ca2+ concentration. TGR5 Receptor Agonist can also reduces food intake and improves insulin responsiveness, in diet-induced obese mice. TGR5 Receptor Agonist can be used to research diabetes, bladder hypersensitivity and anti-obesity[1][2][3][4].
3-iodo-4-[(4-methylpiperazin-1-yl)methyl]benzoic acid
2-(1,3-Benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
C17H13FN2O4S (360.05800300000004)
4-Nitro-benzylphosphonobutanoyl-glycine
C13H17N2O8P (360.07224920000004)
2-Bromo-N-(3-butyramidophenyl)benzamide
C17H17BrN2O2 (360.04733219999997)
2-[2-(1,2-benzisoxazol-3-yl)acetyl]-N-(4-chlorophenyl)-1-hydrazinecarbothioamide
C16H13ClN4O2S (360.04477080000004)
2-[4-Ethoxy-2-[2-furanyl(oxo)methyl]imino-1,3-benzothiazol-3-yl]acetic acid methyl ester
2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide
N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide
4,5-Dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid
1-(4-Chlorophenyl)-2-[[3-(3-methylphenyl)-1,2,4-thiadiazol-5-yl]thio]ethanone
2-bromo-N-[2,3-dihydroindol-1-yl(sulfanylidene)methyl]benzamide
C16H13BrN2OS (359.99319080000004)
(2E,5E)-2-((2-chlorophenyl)imino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one
C17H13ClN2O3S (360.0335378000001)
O-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)ethyl] (4-Chlorophenyl)thiocarbamate
C17H13ClN2O3S (360.0335378000001)
Para-nitrophenyl phosphonobutanoyl D-alanine
C13H17N2O8P (360.07224920000004)
N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine
C13H17N2O8P (360.07224920000004)
4-Phosphonooxy-phenyl-methyl-[4-phosphonooxy]benzen
N1-(5-Phospho-alpha-ribosyl)-5-methoxybenzimidazole
C13H17N2O8P (360.07224920000004)
CID 22635267
C14H6ClF3NO5- (359.98865920000003)
D010575 - Pesticides > D006540 - Herbicides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
[5,6,7,8-Tetrahydroxy-8-(hydroxymethyl)-2-oxo-1,3,9-trioxa-2lambda5-phosphaspiro[3.5]nonan-2-yl] 2-oxopropaneperoxoate
C9H13O13P (360.00937780000004)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide
(E)-2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)furan-2-yl]prop-2-enamide
N-[(E)-(6-chloro-1,3-benzodioxol-5-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-6-carboxamide
C17H13ClN2O5 (360.05129580000005)
(1S,3S,11R,11aR)-3-amino-1,7,11-trihydroxy-4-oxo-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinolin-8-yl hydrogen sulfate
3-(4-Bromophenyl)-5-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole
C16H13BrN2O3 (360.01094880000005)
2-(ethylthio)-4-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazol-5(4H)-one
N-(5-chloro-2-pyridinyl)-2-[(1-phenyl-5-tetrazolyl)thio]propanamide
C15H13ClN6OS (360.05600380000004)
N-(1,3-benzodioxol-5-yl)-6-bromo-2-pyrazolo[1,5-a]pyrimidinecarboxamide
1-(4-Fluorophenyl)-3-methyl-5-thieno[2,3-c]pyrazolecarboxylic acid (2-oxo-3-oxolanyl) ester
C17H13FN2O4S (360.05800300000004)
5-[(2-Bromophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
2-(4-Chlorophenyl)-3-(2-furanylmethyl)imidazo[4,5-b]quinoxaline
N-[[[(2-hydroxyphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
5-(4-Chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
2-Amino-4-(4-chlorophenyl)-1-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile
2-Amino-1-(4-chlorophenyl)-4-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile
2-[[5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester
N-(4-chlorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide
C16H13ClN4O2S (360.04477080000004)
fumisoquin B zwitterion
A zwitterion obtained by transfer of a proton from the sulfate to the amino group of fumisoquin B; major species at pH 7.3.
5-(2-Chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
N-[(E)-[5-(2-chlorophenyl)furan-2-yl]methylideneamino]benzenesulfonamide
C17H13ClN2O3S (360.0335378000001)
N-[4-(4-nitrophenylphospho)butanoyl]alanine
C13H17N2O8P (360.07224920000004)
(2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate
C15H10ClF3NO4- (360.02504260000006)
(4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
C10H17ClN2O4S3 (360.00389520000004)
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-aminium
1-S-[(1Z)-N-(sulfonatooxy)butanimidoyl]-1-thio-beta-D-glucopyranose
(2S)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate
C15H10ClF3NO4- (360.02504260000006)
6-(5-Carboxy-2-hydroxy-3-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)-2-furanyl]-2-propenamide
propylglucosinolate
An alkylglucosinolate that is the conjugate base of propylglucosinolic acid.
fumisoquin B
A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7 and 11R, by an amino group at position 3S, oxo group at position 4 and a sulfooxy group at position 8. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.
Glucoputranjivin(1-)
A alkylglucosinolate that is the conjugate base of glucoputranjivin.
7-Iodo-2',3'-dideoxy-7-deazaadenosine
7-Iodo-2',3'-dideoxy-7-deazaadenosine is a dideoxynucleoside that can be used in DNA synthesis and sequencing reactions[1].
FX-909
C17H10F2N2O3S (360.03801740000006)
FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. FX-909 can be used for the research of cancer[1].
RO0711401
C18H11F3N2O3 (360.07217319999995)
RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM[1][2].
SSR180711 (hydrochloride)
SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus[1].
(2-{[2,3'-bithiophen]-2'-yl}-2h-thiophen-3-ylidene)methyl (2z)-2-methylbut-2-enoate
(2r,3r,5s)-3-bromo-5-(1-chlorohex-3-en-5-yn-1-yl)-2-(3-methoxypent-1-en-1-yl)oxolane
5-chloro-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-methyl-3,4-dihydro-2-benzopyran-1-one
6,12-dihydroxy-7,13,14-trimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
4-[(2z)-but-2-en-2-yl]-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
3,5,3′- tri- Omethylflavellagic acid
{"Ingredient_id": "HBIN007535","Ingredient_name": "3,5,3\u2032- tri- Omethylflavellagic acid","Alias": "NA","Ingredient_formula": "C17H12O9","Ingredient_Smile": "COC1=C(C=C2C3=C1OC(=O)C4=C3C(=C(C(=C4O)OC)OC)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41520","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl (9e,17e)-18-bromooctadeca-9,17-dien-5,7,15-triynoate
4-[(2e)-but-2-en-2-yl]-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
(5-{[2,2'-bithiophen]-5-yl}thiophen-2-yl)methyl (2e)-2-methylbut-2-enoate
4-(but-2-en-2-yl)-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
{3-amino-1,7,11-trihydroxy-4-oxo-1h,2h,3h,6h,11h,11ah-pyrido[1,2-b]isoquinolin-8-yl}oxidanesulfonic acid
(7z)-10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
(5-{[2,2'-bithiophen]-5-yl}thiophen-2-yl)methyl 3-methylbut-2-enoate
4-hydroxy-3-[(1-hydroxy-3,4-dioxonaphthalen-2-yl)methyl]naphthalene-1,2-dione
3-bromo-5-(1-chlorohex-3-en-5-yn-1-yl)-2-(3-methoxypent-1-en-1-yl)oxolane
methyl 6-bromooctadeca-5,15-dien-11,13,17-triynoate
(1s,2r,4r,5r,7z,9r,10r,12s)-10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
(2r,3r,5s)-3-bromo-5-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z,3r)-3-methoxypent-1-en-1-yl]oxolane
(5-{[2,2'-bithiophen]-5-yl}thiophen-2-yl)methyl 2-methylbut-2-enoate
4-(3-bromopropa-1,2-dien-1-yl)-2-methyl-3,13-dioxabicyclo[8.2.1]tridec-5-ene-7,9,12-triol
C15H21BrO5 (360.05722760000003)
methyl 18-bromooctadeca-9,17-dien-5,7,15-triynoate
5-hydroxy-16-methyl-13,21-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-1(14),2(11),4,6,8,15,17,19-octaene-3,10,22-trione
8-hydroxy-6,15-dimethyl-12,20-dioxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17-octaene-3,10,21-trione
(2r,3r,5s)-3-bromo-5-[(3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z)-3-methoxypent-1-en-1-yl]oxolane
methyl 18-bromooctadeca-13,17-dien-5,7,15-triynoate
methyl (9z,17e)-18-bromooctadeca-9,17-dien-5,7,15-triynoate
3-chloro-1,2,6,7-tetrahydroxy-3-methyl-1h,2h-cyclohexa[a]fluorene-4,11-dione
C18H13ClO6 (360.04006280000004)
(5-{[2,2'-bithiophen]-5-yl}thiophen-2-yl)methyl (2z)-2-methylbut-2-enoate
(2-{[2,3'-bithiophen]-2'-yl}-2h-thiophen-3-ylidene)methyl 3-methylbut-2-enoate
methyl (13e,17e)-18-bromooctadeca-13,17-dien-5,7,15-triynoate
(1s,2s,4s,5e,7r,9s,10s,12r)-4-(3-bromopropa-1,2-dien-1-yl)-2-methyl-3,13-dioxabicyclo[8.2.1]tridec-5-ene-7,9,12-triol
C15H21BrO5 (360.05722760000003)
2-hydroxy-3-[(3-hydroxy-1,4-dioxonaphthalen-2-yl)methyl]naphthalene-1,4-dione
methyl (5e,15z)-6-bromooctadeca-5,15-dien-11,13,17-triynoate
(2-{[2,3'-bithiophen]-2'-yl}-2h-thiophen-3-ylidene)methyl (2e)-2-methylbut-2-enoate
10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
(1r,2s,3r)-3-chloro-1,2,6,7-tetrahydroxy-3-methyl-1h,2h-cyclohexa[a]fluorene-4,11-dione
C18H13ClO6 (360.04006280000004)